With activation of IL-1 signaling an essential step in the pathogenesis of autoimmune KCS, the next step was to test whether local inhibition of the IL-1R1 pathway provided an effective therapy for aqueous-deficient dry eye. The gene discussed is IL1B; the disease is Keratoconjunctivitis sicca.